AHP1947 recognises Secobarbital, one of around 12 compounds derivatised from barbituric acid. These compounds are central nervous system depressants and are commonly used as sedatives, anaesthetics, hypnotics and anticonvulsants. They can be classified into three groups: ultra-short-acting (clinically used as anaesthetics), short/intermediate-acting and long-acting (clinically used as anticonvulsants). Barbiturates are addictive and potentially very dangerous, producing feelings of tranquillity, but overdose can lead to a dramatic fall in blood pressure and body temperature, depressed respiration and coma. The short-acting barbiturates are the most favoured by recreational drug users.
Secobarbital is indicated for the treatment of epilepsy, insomnia and as a pre-operative medication to induce anaesthesia and anxiolysis. It is commonly used as a recreational drug.
Application
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visitwww.abdserotec.com/protocols.
Application Name
Yes
No
Not Determined
Suggested Dilution
ELISA
5ug/ml -
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using the appropriate negative/positive controls.
Storage
Store at +4oC or at -20oC if preferred.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
京公网安备11010802025653 版权所有：北京逸优科技有限公司
